Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
ELF4 Drives Colorectal Cancer Metastasis via FGFR4 and SRC A
2026-07-24
This study demonstrates that FGF19-mediated overexpression of ELF4 promotes colorectal cancer metastasis through transcriptional activation of FGFR4 and SRC. These findings highlight ELF4 as a potential therapeutic target and biomarker for aggressive metastatic disease.
-
PD 173074: Precision FGFR/VEGFR Inhibition for Translational
2026-07-24
Explore the mechanistic and strategic dimensions of PD 173074 as a selective FGFR1/VEGFR2 inhibitor, with actionable guidance for translational researchers. Dive into evidence-based insights on pathway inhibition, protocol optimization, and the evolving competitive landscape in cancer research and beyond.
-
PF-573228: Advanced FAK Inhibitor Workflows in Dentinogenesi
2026-07-23
PF-573228 stands out as a highly selective FAK inhibitor, enabling precise dissection of mechanotransduction pathways in dental tissue engineering. Applied in stiffness-driven dentinogenesis models, it empowers researchers to unravel cell–material interface signaling with superior specificity and reproducibility.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-07-23
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides a visible, EDTA-free molecular weight reference for SDS-PAGE and Western blot workflows, supporting accurate monitoring of protein separation and transfer without requiring extra buffer or heat incubation. It is not suitable for applications requiring unstained standards or absolute quantification.
-
HyperScript™ Reverse Transcriptase in Retinal Disease Resear
2026-07-22
Explore how HyperScript™ Reverse Transcriptase empowers advanced cDNA synthesis for qPCR in retinal disease models, including nuanced gene expression profiling in complex tissues. This article delivers a unique, evidence-based analysis linking enzyme technology to translational insights.
-
Potassium Iodide (KI): Molecular Precision in Thyroid and Im
2026-07-22
Explore the molecular mechanisms and advanced research applications of Potassium Iodide (KI), including its pivotal role in thyroid protection and as a precision tool in immuno-oncology workflows. This article provides unique insights into its solubility, assay design, and integration with next-generation nanotechnology.
-
Meropenem in Antibacterial Research: Resistance Modeling and
2026-07-21
Explore the advanced use of Meropenem as a β-lactam antibiotic carbapenem for research on Gram-negative and Gram-positive bacteria. This article uniquely dissects resistance gene transmission and delivers actionable guidance for precision assay design.
-
Practical Use of Cy5 NHS ester(Et) for Biomolecule Labeling
2026-07-21
Cy5 NHS ester(Et) is a water-soluble fluorescent dye designed for rapid and stable labeling of primary amines in proteins and other biomolecules. Researchers should avoid ethanol-based workflows and long-term storage of dye solutions to ensure labeling efficiency and reproducibility. This reagent is best suited for applications such as immunofluorescence staining, flow cytometry, and fluorescence microscopy.
-
Asiaticoside Blocks TGF-β1-Induced MMT and Oxidative Stress
2026-07-20
Zhao et al. demonstrated that asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition (MMT) and oxidative stress in human peritoneal mesothelial cells (HPMCs) through activation of the Nrf2/HO-1 pathway. This mechanistic insight provides new directions for targeting peritoneal fibrosis, highlighting the interplay between TGF-β/Smad and oxidative stress signaling.
-
Sulfachloropyridazine: Mechanism, Evidence, and Research Uti
2026-07-20
Sulfachloropyridazine is a broad-spectrum sulfonamide antibacterial agent used in microbiological research. It inhibits bacterial folate synthesis through competitive DHPS inhibition, with potent, strain-dependent effects on diverse pathogens. Recent studies highlight its role in microbial ecology and in vivo infection models.
-
Salvianolic Acid B Inhibits LH2 to Reduce Collagen in Pulmon
2026-07-19
This study demonstrates that Salvianolic acid B (Dan Shen Suan B) serves as a targeted inhibitor of lysyl hydroxylase 2 (LH2), reducing pathological collagen cross-linking and deposition in pulmonary fibrosis. The findings offer mechanistic evidence for the compound's antifibrotic activity and highlight its translational potential as an extracellular matrix remodeling agent.
-
n-Dodecyl-β-D-maltoside (C4421): Reliable Membrane Protein A
2026-07-18
This article provides a scenario-driven, evidence-based guide for biomedical researchers seeking reproducibility in membrane protein workflows using n-Dodecyl-β-D-maltoside (SKU C4421). Drawing on real laboratory challenges, we demonstrate how DDM enhances solubilization, protein stability, and assay fidelity, with actionable recommendations supported by recent structural biology breakthroughs.
-
Sulfachloropyridazine Modulates Microbiota in E. tenella Inf
2026-07-17
This study provides an integrated analysis of sulfachloropyridazine and ethanamizuril, alone and in combination, on the cecal microbial and metabolomic profiles of chickens infected with Eimeria tenella. The findings clarify drug-specific impacts on pathogenic bacteria and metabolic perturbations, informing targeted antimicrobial and infection model studies.
-
Artemisinin Mitigates Diabetic Cognitive Decline via NRF2 Re
2026-07-17
Wang et al. (2024) provide compelling evidence that artemisinin alleviates cognitive impairment in type 2 diabetic mice by activating NRF2 and suppressing neuronal ferroptosis in the hippocampus. Their work highlights the mechanistic role of NRF2 signaling pathway inhibition and ferroptosis modulation in diabetic cognitive deficits, suggesting new avenues for neuroprotective intervention.
-
BAY-826: Potent Small Molecule Inhibitor for Retinal Models
2026-07-16
BAY-826 streamlines retinal neurovascular research by enabling precise, nanomolar inhibition of critical signaling nodes in angiopoietin and PEDF pathways. Its high selectivity and robust performance empower advanced co-culture and hypoxia assays, with flexible workflows and reproducible results.
8662 records 6/578 page Previous Next First page 上5页 678910 下5页 Last page